Search - tctmd.com

Displaying 121 - 140 of 242

Sort: Relevancy | Date

News Conference News ISET 2018

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

Caitlin E. Cox

February 05, 2018

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

L.A. McKeown

December 04, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

Presentation TCT 2017

Italy Presents a Case: STEMI Due to Left Main Disease

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Ugo Limbruno

October 30, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Industry News

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

July 12, 2017

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

L.A. McKeown

April 10, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Industry News

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

February 09, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

July 13, 2016

Presentation CCVVC 2016

Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not?

Presenter: Marianne Brodmann

June 15, 2016

News Daily News

Statins Tied to Lower Mortality, Amputation Risks in PAD

Michael O'Riordan

May 09, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

Advertisement

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

Burden of Readmission High in PAD Patients Following Revascularization

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Italy Presents a Case: STEMI Due to Left Main Disease

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

Readmission for Critical Limb Ischemia Common and Largely Unplanned

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not?

Statins Tied to Lower Mortality, Amputation Risks in PAD

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content